Abstract
Cervical cancer is one of the leading causes of cancer deaths worldwide. The ample majority of these cases are squamous carcinomas, whereas most of the remaining cases represent adenocarcinoma. A few examples of mixed tumors, including carcinosarcoma, adenosarcoma, and other tumor types such as melanoma have also been described. All are described and pictured herein.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumors of female reproductive organs. 4th ed. Lyon: IARC Press; 2014. p. 170–97.
Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health (Larchmont). 2012;21:1031–7.
Bulk S, Berkhof J, Bulkmans NWJ, Zielinski GD, Rozendaal L, van Kemenade FJ, et al. Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in the Netherlands. Br J Cancer. 2006;94:171–5.
Roma AA, Fadare O. The pattern is the issue: recent advances in adenocarcinoma of the uterine cervix. Virchows Arch. 2018;472:897–905.
Park KJ, Roma AA. Pattern based classification of endocervical adenocarcinoma: a review. Pathology. 2018;50:134–40.
Roma AA, Mistretta TA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, et al. New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome. Gynecol Oncol. 2016;141:36–42.
Missaoui N, Mestiri S, Bdioui A, Zahmoul T, Hamchi H, Mokni M, Hmissa S. HPV infection and p16INK4A and TP53 expression in rare cancers of the uterine cervix. Pathol Res Pract. 2018;214:498–506.
Kenny SL, McBride HA, Jamison J, McCluggage WG. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β. Am J Surg Pathol. 2012;36:799–807.
Howitt BE, Emori MM, Drapkin R, Gaspar C, Barletta JA, Nucci MR, et al. GATA3 is a sensitive and specific marker of benign and malignant mesonephric lesions in the lower female genital tract. Am J Surg Pathol. 2015;39:1411–9.
Roma AA, Goyal A, Yang B. Differential expression patterns of GATA3 in uterine mesonephric and nonmesonephric lesions. Int J Gynecol Pathol. 2015;34:480–6.
Tcheung WJ, Selim MA, Herndon JE, Abernethy AP, Nelson KC. Clinicopathologic study of 85 cases of melanoma of the female genitalia. J Am Acad Dermatol. 2012;67:598–605.
Gallardo A, Prat J. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. Am J Surg Pathol. 2009;33:278–88.
Howitt BE, Quade BJ, Nucci MR. Uterine polyps with features overlapping with those of müllerian adenosarcoma: a clinicopathologic analysis of 29 cases emphasizing their likely benign nature. Am J Surg Pathol. 2015;39:116–26.
Soslow RA. Mixed müllerian tumors of the female genital tract. Surg Pathol Clin. 2009;2:707–30.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fadare, O., Roma, A.A. (2019). Epithelial and Mixed Epithelial/Mesenchymal Malignancies of the Cervix. In: Atlas of Uterine Pathology. Atlas of Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-17931-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-17931-1_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17930-4
Online ISBN: 978-3-030-17931-1
eBook Packages: MedicineMedicine (R0)